Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to cyclopentano-hydrophenanthrene ; derivative thereof
Patent
1993-11-15
1995-06-27
Geist, Gary
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to cyclopentano-hydrophenanthrene ; derivative thereof
128654, A61K 5100, A61B 600
Patent
active
054277663
ABSTRACT:
A method for detection and localization of tissues having estrogen receptors during surgery is disclosed. The method involves administering an effective amount of an estradiol derivative labeled with a radionuclide to a patient and then delaying surgery for a time interval for permitting the labeled estradiol derivative to localize in the tissue. Thereafter, an operative field of the animal is surgically accessed an the tissue within the operative filed examined with a probe to detect photon emission from the labeled estradiol derivative.
REFERENCES:
patent: 4272530 (1981-06-01), Teutsch et al.
patent: 4676932 (1987-06-01), Hylarides et al.
patent: 4725426 (1988-02-01), Hofmeister et al.
patent: 4782840 (1988-11-01), Martin et al.
patent: 4801803 (1989-01-01), Denen et al.
patent: 4882141 (1989-11-01), Baranczuk et al.
patent: 4885117 (1989-12-01), Hofmeister et al.
patent: 4893013 (1990-01-01), Denen et al.
patent: 4945064 (1990-07-01), Hofmeister et al.
patent: 5002753 (1991-03-01), Zeicher et al.
patent: 5070878 (1991-12-01), Denen
patent: 5096694 (1992-03-01), Quivy et al.
patent: 5204337 (1993-04-01), Labrie et al.
patent: 5215972 (1993-06-01), Cassal et al.
Sasson et al., "Reversible, Positive Cooperative Interaction of 11.beta.-Chloromethyl-[Hu 'H]estradiol-17.beta. with the Calf Uterine Estrogen Receptor", J. Steroid BioChem., 33, No. 5, 859-865, 1989.
Hanson et al., "Synthesis, Receptor Binding and Tissue Distribution of 17.alpha.-E[.sup.125 ]iodovinyl-11.beta.-ethyl-estradiol", Nucl. Med. Biol., 20, No. 3, 351-358 (1993).
Bindal et al., "11.beta.-Chloromethyl-[.sup.3 H]estradiol-17 .beta.: A Very High Affinity, Reversible Ligand for the Estrogen Receptor", J. Steroid Biochem., 28, No. 4, 361-370 (1987).
Ratajczak et al., "A Comparison of 11.beta.-Chloromethlylestradiol and Tamoxifen Aziridine as Affinity Labeling Reagents for Estrogen Receptors", Steroids, 51, 5-6, 499-518, May-Jun. 1988.
Cummins, "A Steroids Review Radiolabeled Steroidal Estrogens in Cancer Research", Steroids, 58, 245-259, Jun. 1993).
Chapman Lara E.
Geist Gary
The Dow Chemical Company
LandOfFree
Radiolabeled steroids for use in radiochemical-guided surgery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled steroids for use in radiochemical-guided surgery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled steroids for use in radiochemical-guided surgery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-285419